Fadi G Haddad

Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia

E. Jabbour, G. Issa, M. Yilmaz, 2022, Expert opinion on pharmacotherapy.

A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer.

T. Assi, Ziad Bakouny, J. Kattan, 2018, Immunotherapy.

Aorto-atrial fistula 10 days after dissection repair in giant cell arteritis.

I. El-rassi, V. Jebara, F. Haddad, 2008, The Annals of thoracic surgery.

Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors

G. Garcia-Manero, J. Cortes, T. Kadia, 2022, American journal of hematology.

Acute Nonimmune Hemolytic Anemia Without Fulminant Hepatitis in Wilson Disease

A. Agrawal, A. Matsunaga, Fadi G Haddad, 2011, Journal of pediatric hematology/oncology.

PD-L1 protein expression by Combined Positive Score (CPS) in patients with muscle invasive or advanced urothelial carcinoma: a single institution experience

J. Kattan, V. Trak-Smayra, S. Nasr, 2023, BMC Cancer.

Acute Nonimmune Hemolytic Anemia Without Fulminant Hepatitis in Wilson Disease

A. Agrawal, A. Matsunaga, Fadi G Haddad, 2011, Journal of pediatric hematology/oncology.